The Role of Peptides in Sports Medicine written by Anfield Index News Team on February 28, 2025 for AnfieldIndex.com ...

CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US.

This >€500 million investment will feature multiple manufacturing lines capable of supporting small, medium, and large-scale peptide production with small- to large-scale Solid Phase Peptide ...

CordenPharma is excited to deliver flexible peptide manufacturing support at its state-of-the-art Greenfield site near Basel, Switzerland. This >€500 million investment will feature multiple ...

[Photo by CordenPharma] An aerial sketch of CordenPharma's future peptide manufacturing facility located at Getec Park in Muttenz, Switzerland. This >€500 million investment will feature multiple ...

After earmarking a major chunk of change last year to bulk up in peptide production, European CDMO CordenPharma is putting ...

This >€500 million investment will feature multiple manufacturing lines capable of supporting small, medium, and large-scale peptide production with small- to large-scale Solid Phase Peptide Synthesis ...